Expertise in
28
conditions

Florence Lacaille

149, Sèvres Street, 
Paris, FR 
Expertise in
28
conditions
149, Sèvres Street, 
Paris, FR 

Overview

Florence Lacaille practices in Paris, France. Ms. Lacaille is highly rated in 28 conditions, according to our data. Her top areas of expertise are Alagille Syndrome, Cholestasis, Progressive Familial Intrahepatic Cholestasis Type 1, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

Her clinical research consists of co-authoring 139 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Female

Locations

149, Sèvres Street, Paris, 75015, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

POLYGEN DEFI-ALPHA : Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort
POLYGEN DEFI-ALPHA : Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort
Enrollment Status: Completed
Publish Date: December 19, 2025
Intervention Type: Other
Study Phase: Not Applicable
Open-Label, Phase 2 Study to Evaluate the Safety and Tolerability of Maralixibat in the Treatment of Infants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis and Alagille Syndrome
Open-Label, Phase 2 Study to Evaluate the Safety and Tolerability of Maralixibat in the Treatment of Infants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis and Alagille Syndrome
Enrollment Status: Completed
Publish Date: February 06, 2025
Intervention Type: Drug
Study Drug: Maralixibat
Study Phase: Phase 2
A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT)
A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: Odevixibat
Study Phase: Phase 3
View 2 Less Clinical Trials

139 Total Publications

Condition-Specific Growth Charts for Children With Alagille Syndrome.
Condition-Specific Growth Charts for Children With Alagille Syndrome.
Journal: JAMA network open
Published: November 24, 2025

Frequently Asked Questions about Florence Lacaille

Is Florence Lacaille a top-rated expert for Alagille Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Florence Lacaille is classified as an Elite expert for Alagille Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Florence Lacaille participate in research or clinical trials?

Yes. Florence Lacaille has published 139 articles and abstracts on conditions like Alagille Syndrome. You can view a list of Florence Lacaille's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lacaille's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 19 Advanced Conditions
View All 66 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile